dc.creator | Rodríguez- Pintó, Ignasi | |
dc.creator | Cervera, Ricard | |
dc.date.accessioned | 2017-02-07T15:17:08Z | |
dc.date.accessioned | 2022-10-20T20:14:39Z | |
dc.date.available | 2017-02-07T15:17:08Z | |
dc.date.available | 2022-10-20T20:14:39Z | |
dc.date.created | 2017-02-07T15:17:08Z | |
dc.date.issued | 2016-12 | |
dc.identifier | 1390-4450 | |
dc.identifier | http://dspace.ucuenca.edu.ec/handle/123456789/26623 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4595184 | |
dc.description.abstract | The term anti-phospholipid syndrome (APS) “catastrophic”
was introduced to define a serious and rapidly
progressive form of APS which leads to multi-organ failure.
Patients with catastrophic APS have in common: a)
a clinical evidence of multiple organ involvement (3 or
more organs); b) pathological evidence of occlusion of
multiple small vessels (although some patients have also
thrombosis of large vessels) and c) confirmation of the
presence of anti-phospholipid antibodies (APAs), usually
at high titers.
Although they represent less than 1% of all patients with
APS, they usually found in an urgent medical situation
that requires a thorough clinical monitoring and an early
and vigorous treatment | |
dc.language | eng | |
dc.publisher | Universidad de Cuenca. Facultad de Ciencias Médicas | |
dc.relation | 610.5;200434 | |
dc.subject | Sindrome Antifosfolipidico | |
dc.subject | Anticuerpos Antifosfolipidicos | |
dc.subject | Anticuerpos Anticardiolipina | |
dc.subject | Inhibidor De Coagulacion Del Lupus | |
dc.subject | Inmunoglobulinas Intravenosas | |
dc.subject | Intercambio Plasmatico | |
dc.title | Síndrome antifosfolipídico catastrófico | |
dc.type | Article | |